Search - tctmd.com

Displaying 461 - 480 of 2327

Sort: Relevancy | Date

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT Abstracts 2024

Right Ventricular-Pulmonary Arterial Coupling in Tricuspid Regurgitation†and Implications of Transcatheter Tricuspid Valve Repair 2013 A Propensity Score Matched Analysis

Presenter: Karl-Philipp Rommel

March 04, 2024

Presentation THT Abstracts 2024

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Presenter: Charles Sherrod

March 04, 2024

Presentation THT Abstracts 2024

Role of Invasive Exercise Hemodynamics in Symptomatic Secondary Mitral Regurgitation Prior to Transcatheter Edge-to-Edge Repair

Presenter: Bassim El-Sabawi

March 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

Advertisement

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Debate Continues on TAVI Choice for Women With Small Annuli

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

TCTMD’s Top 10 Most Popular Stories for March 2024

FDA Approves TriClip TEER Device for Tricuspid Repair

April 2024 Dispatch for the CV Team

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Debating the Role of T-TEER in the Sickest Patients

Right Ventricular-Pulmonary Arterial Coupling in Tricuspid Regurgitation†and Implications of Transcatheter Tricuspid Valve Repair 2013 A Propensity Score Matched Analysis

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Role of Invasive Exercise Hemodynamics in Symptomatic Secondary Mitral Regurgitation Prior to Transcatheter Edge-to-Edge Repair

TCTMD’s Top 10 Most Popular Stories for February 2024

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content